These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 25695438

  • 1. Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate-transfused patients.
    Jain N, Sarkar S, Philip J.
    Immunohematology; 2014; 30(3):123-5. PubMed ID: 25695438
    [Abstract] [Full Text] [Related]

  • 2. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S.
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [Abstract] [Full Text] [Related]

  • 3. Identification of platelet refractoriness in oncohematologic patients.
    Ferreira AA, Zulli R, Soares S, Castro Vd, Moraes-Souza H.
    Clinics (Sao Paulo); 2011 Feb; 66(1):35-40. PubMed ID: 21437433
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused Patients.
    Sarkar RS, Philip J, Jain N.
    Indian J Hematol Blood Transfus; 2015 Mar; 31(1):77-84. PubMed ID: 25548450
    [Abstract] [Full Text] [Related]

  • 6. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H, Bertrand G, Zitouni S, Djenouni A, Martageix C, Griffi F, Kaplan C, Ouelaa H.
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A, Picard C.
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y, Li W, Liu N, Zhang K, Gong Z, Li D, Wang L, Wang D, Jing Y, Wang J, Shan X.
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group.
    N Engl J Med; 1997 Dec 25; 337(26):1861-9. PubMed ID: 9417523
    [Abstract] [Full Text] [Related]

  • 13. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients].
    Schnaidt M, Wernet D, Mayer G, Northoff H.
    Beitr Infusionsther Transfusionsmed; 1994 Dec 25; 32():240-3. PubMed ID: 9480099
    [Abstract] [Full Text] [Related]

  • 14. [Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM].
    Dettori I, Ladaique P.
    Transfus Clin Biol; 2014 Nov 25; 21(4-5):207-9. PubMed ID: 25267204
    [Abstract] [Full Text] [Related]

  • 15. Platelet immunology. ELISA for detection of platelet antibodies, platelet-specific antigens and platelet glycoproteins.
    Taaning E.
    Dan Med Bull; 1992 Aug 25; 39(4):343-54. PubMed ID: 1382006
    [Abstract] [Full Text] [Related]

  • 16. Frequency and causes of refractoriness in multiply transfused patients.
    Legler TJ, Fischer I, Dittmann J, Simson G, Lynen R, Humpe A, Riggert J, Schleyer E, Kern W, Hiddemann W, Köhler M.
    Ann Hematol; 1997 Apr 25; 74(4):185-9. PubMed ID: 9174547
    [Abstract] [Full Text] [Related]

  • 17. Alloimmunization to platelets in heavily transfused patients with sickle cell disease.
    Friedman DF, Lukas MB, Jawad A, Larson PJ, Ohene-Frempong K, Manno CS.
    Blood; 1996 Oct 15; 88(8):3216-22. PubMed ID: 8874223
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP, Nambiar A.
    Transfusion; 2012 Oct 15; 52(10):2146-54. PubMed ID: 23113654
    [Abstract] [Full Text] [Related]

  • 20. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions.
    Lo SC, Lin DT, Lin SW, Chang JS.
    J Formos Med Assoc; 2000 Dec 15; 99(12):902-5. PubMed ID: 11155742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.